Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Gibson currently holds 4,443,334 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Gibson has been a net seller of RXRX stock. They have purchased $0 and sold $36.8M worth of shares.
Christopher Gibson's most recent insider trade was on Apr 7, 2026, when they sold 40,000 shares at $0.00 per share.
Christopher Gibson serves as Executive at RECURSION PHARMACEUTICALS, INC. (RXRX). They have executed 559 insider transactions totaling $36.8M over their tenure at the company.
Christopher Gibson holds the position of Executive at RECURSION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Christopher Gibson has shown a selling trading pattern, with $0 in total purchases and $36.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Gibson was on Oct 10, 2025, when they sold $604.0K worth of RXRX shares. This transaction involved 100,000 shares at $6.04 per share.
Christopher Gibson currently owns 4,443,334 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Gibson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Gibson has 559 Form 4 filings on record as an insider at RECURSION PHARMACEUTICALS, INC..
Set alerts for Christopher Gibson and 40,000+ other insiders.